TrialLower urinary tract symptoms2021

Cardiovascular safety of mirabegron add-on therapy to tamsulosin for the treatment of overactive bladder in men with lower urinary tract symptoms: A post hoc analysis from the MATCH study.

Takao Katoh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.